Avania Acquires IMARC
June 22, 2021
Avania, a global medical-technology contract research organization (CRO) based in Bilthoven, Netherlands, has acquired IMARC, a Strongsville, Ohio–based medical device CRO. The acquisition expands Avania's U.S. footprint and capabilities in device clinical research (monitoring, auditing, safety, data management and training) while providing IMARC clients access to Avania's international network and enhanced services.
- Buyers
- Avania
- Targets
- IMARC
- Industry
- Healthcare Services
- Location
- Ohio, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Avania Acquires Anagram
October 8, 2024
Healthcare Services
Avania, a global MedTech contract research organization (CRO), has acquired Anagram, a Barcelona-based MedTech CRO, to expand its CRO footprint into Spain and Southern Europe. The acquisition adds Anagram’s imaging core lab and therapeutic expertise in cardiology, neurology and oncology, strengthening Avania’s regional presence and clinical capabilities.
-
Avania Acquires MAXIS
February 7, 2023
Medical Devices
Avania, the Bilthoven-based MedTech-focused contract research organization (CRO), has acquired MAXIS, a medical-technology development services provider with offices in San Jose, California and Frankfurt am Main, Germany. The deal expands Avania's pre-clinical engineering, design validation, regulatory affairs, and field clinical/trial management capabilities and extends its international footprint.
-
Astorg Acquires Majority Stake in Avania
June 20, 2022
Healthcare Services
Astorg has acquired a majority stake in Avania from Kester Capital, with Kester expected to retain a minority position and management also reinvesting. Avania, a Bilthoven-headquartered MedTech-focused clinical CRO, will use Astorg's capital and network to accelerate organic growth and pursue M&A to build a scaled, global MedTech CRO platform.
-
Avania Acquires Hull Associates LLC and Ironstone Product Development (IPD)
October 17, 2023
Healthcare Services
Avania, a global MedTech contract research organization based in the Netherlands, has acquired HULL ASSOCIATES LLC (Boston) and Ironstone Product Development (IPD) (Toronto) to strengthen its engineering design, product development, regulatory, and market access capabilities across medical devices, diagnostics and related product categories. The acquisitions expand Avania's strategic expertise in market access/reimbursement, health economics, early product development, and regulatory strategy to better support MedTech innovators from development through commercialization.
-
The IMA Group Acquires Amici Clinical Research
March 2, 2022
Healthcare Services
The IMA Group's Clinical Research division acquired Amici Clinical Research, adding two New Jersey clinical trial sites (Raritan and Hoboken) to IMA's network. The acquisition expands IMA's Northeast footprint and therapeutic capabilities across areas including fatty liver, cardiovascular, pulmonary and neurologic diseases, and supports site-based, hybrid and decentralized trials.
-
Veranex Acquires IMMR (Paris-based Preclinical Services)
October 12, 2021
Medical Devices
Veranex, a global concept-to-commercialization service provider for the MedTech industry, has acquired IMMR, a Paris-based preclinical science organization providing GLP-compliant preclinical research, pathology evaluation and surgical training. The acquisition expands Veranex's preclinical capabilities with IMMR's FDA-inspected and AAALAC-accredited facilities and expert surgical teams; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.